Surveillance, Epidemiology, And End Results (SEER) 2013

IDIQ

Description

Provide population-based central cancer registries in order to collect and report data on cancer incidence, treatment, and survival in the general population. The Surveillance Epidemiology and End Results (SEER) Program is the National Cancer Institute's main resource for tracking changes in cancer incidence, morbidity, and mortality.

Overview

Ceiling

$275,000,000

Primary Sponsoring Agency

National Cancer Institute (NCI) [HHS - NIH]

Who Can Use

One Agency

Primary NAICS

541712 - Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology)

Primary PSC

AN11 - Health R&D Services; Health Care Services; Basic Research

Primary Set Aside

None

Extent Competed

Not Competed

Successor

Surveillance, Epidemiology, And End Results (SEER) 2018

Surveillance, Epidemiology, And End Results (SEER) 2013 awarded by National Cancer Institute (NCI) in August 2013 accepts orders through July 2017. The IDIQ has a reported ceiling of $275,000,000, and as of today, $184,348,148 has been obligated through the vehicle with a total reported backlog of $727,225 and funded backlog of $93,215 from all task orders, though the ordering period has ended so backlog may not be realized. The IDIQ was awarded full & open and has a primary NAICS code of 541712.

Award Hierarchy

Vehicle

Surveillance, Epidemiology, And End Results (SEER) 2013

Indefinite Delivery Vehicles

Prime Contracts

Subcontracts

Status

Period of Performance

8/1/13

Start Date

7/31/17

Ordering Period End Date

100% Complete

Task Order Obligations and Backlog

$184.3M

Total Obligated

$184.4M

Current Award

$185.1M

Potential Award

100% Funded

$93.2K

Funded Backlog

$727.2K

Total Backlog

Vehicle Award Share

Contractors with greatest percentage of obligations for Surveillance, Epidemiology, And End Results (SEER) 2013

Vehicle Award Share

Federal Award Analysis